
Coronavirus: Commission completes vaccines portfolio following talks with a sixth manufacturer
Published on September 8, 2020
European Commission Press release Brussels, 09 Sep 2020 The European Commission has today concluded exploratory talks with BioNTech-Pfizer to purchase a potential vaccine against COVID-19.
